Applied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2025 Earnings Call Transcript
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2025 Earnings Call Transcript February 13, 2025Applied DNA Sciences, Inc. misses on earnings expectations.
Applied Dna Sciences Inc (APDN)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Connective Capital Management Rob Romero | 3,572.3 | $36,437 | 0.04% | |
| 2. | Millennium Management Israel Englander | 2,697.7 | $27,517 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.25 | 110,000 | Other | 245,000 | 2020-06-26 | Filing | |
| $8.65 | 80,000 | Other | 135,000 | 2020-06-26 | Filing | |
| $5.25 | 40,000 | Other | 215,000 | 2020-06-18 | Filing | |
| $5.25 | 75,000 | Other | 175,000 | 2020-06-09 | Filing | |
| $7.91 | 40,000 | Other | 100,000 | 2020-06-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.52 | 29 | Director | 250 | 2021-03-10 | Filing | |
| $8.51 | 201 | Director | 279 | 2021-03-10 | Filing | |
| $8.45 | 610 | Director | 480 | 2021-03-10 | Filing | |
| $8.47 | 210 | Director | 1,090 | 2021-03-10 | Filing | |
| $8.43 | 11,999 | Director | 1,300 | 2021-03-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,500 | $20,750 | 0% | |
| 2. | 2 | $3 | 0% | |
| 3. | 1 | $1 | 0% | |
| 4. | 0 | $0 | 0% | |
| 5. | 1 | $0 | 0% |
News See All
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q3 2024 Earnings Call Transcript
Operator: Good day, and welcome to the Applied DNA Fiscal Third Quarter 2024 Investor Conference Call. All participants will be listen-only mode. [Operator Instructions].
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2024 Earnings Call Transcript
Operator: Good day and welcome to the Applied DNA Sciences Fiscal First Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2023 Earnings Call Transcript
Operator: Good Day and welcome to the Applied DNA Sciences Fiscal Fourth Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q3 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Applied DNA Sciences Inc. Fiscal Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] Please note, this event is being recorded.
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q2 2023 Earnings Call Transcript
Operator: Hello and welcome to the Applied DNA Sciences Fiscal Second Quarter 2023 Financial Results. All parties will be in listen-only mode. [Operator Instructions].
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q1 2023 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Applied DNA Sciences' First Quarter Fiscal 2023 Financial Results Conference Call. All participants will be in a listen-only mode.
Applied DNA Sciences, Inc. (NASDAQ:APDN) Q4 2022 Earnings Call Transcript
Operator: Good afternoon, and welcome to the Applied DNA Sciences Fourth Quarter and Fiscal Year 2022 Financial Results Conference Call. All participants will be in a listen-only mode.
10 Healthcare and Biotech Stocks to Buy Amid Monkeypox Threat
In this article, we will look at 10 healthcare and biotech stocks to buy amid the monkeypox threat.
Billionaire Hedge Funds
